Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of prime solution on fluid balance after cardiac surgery
2008-001225-34Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Sep 2008
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydroxyethyl starch 130/0.42 in coronary arteriosclerosis (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: Extravascular lung water. Started Sep 2008; status: completed.
02
Drugs
hydroxyethyl starch 130/0.42
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-001225-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001225-34.